CK19, CK20, EGFR and HER2 status of circulating tumor cells in patients with breast cancer.
Tunca B, Egeli U, Cecener G, Tezcan G, Gökgöz S, Tasdelen I, Bayram N, Tolunay S, Umut G, Demirdogen E, Erturk E, Ak S, Cetintas S, Evrensel T.
Tunca B, et al. Among authors: gokgoz s.
Tumori. 2012 Mar-Apr;98(2):243-51. doi: 10.1177/030089161209800211.
Tumori. 2012.
PMID: 22677992